Figure 7
From: A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
Winn assay. Control: 4x105 tumor cells in RPMI medium; Group I: 4x105 tumor cells + 7x105 spleen cells from CBi− EL; Group II: 4x105 tumor cells + 7x105 spleen cells from CBi/L EL. a) Curves were fitted to an exponential growth equation (P < 0,0001); b) Survival proportions (P = 0.001, Log-rank Mantel-Cox test); c) TvDT (N.S. Kruskal-Wallis test); d) Latency time (P = 0.002, Kruskal-Wallis test).